BioMed Technology Among Pioneering Recipients of Investment from CUHK Innovation Limited for Microbiome-based Healthcare Solutions

0
HONG KONG SAR – Media OutReach Newswire – 26 April 2024 – BioMed Technology Holdings Limited (“BioMed“), a start-up founded by CUHK professors and alumni, announced an investment received from CUHK Innovation Limited.

https://biomed.hk/

The issuer is solely responsible for the content of this announcement.

About BioMed Technology Holdings Limited

BioMed Technology Holdings Limited (BioMed), a startup nurtured by Hong Kong Science Park, was founded by a group of CUHK professors and alumni. It advocates precise and personalised microbiome-based healthcare solutions based on DNA testing results, to restore the balance of oral, skin and gut microbiome.

BioMed has raised funds in its oversubscribed seed round from Alibaba Hong Kong Entrepreneurs Fund (AEF), Gobi Partners GBA, The International Medical Co. Ltd. (TIMC) and Human Health Holdings Limited (1419.HK). DSS (NYEX: DSS), a US listed company is also a shareholder of BioMed.

About CUHK Innovation Limited

CUHK Innovation Limited is a newly established company wholly owned by CUHK to make investments in innovative business and impact ventures related to CUHK’s technological innovations. CUHK Innovation Limited will start with an early-stage fund, with a focus on seeking matching funds from venture capital investors.

The Company is committed to supporting CUHK’s spin-off companies as they commercialise their innovative research and development achievements, and furthering the University’s mission in promoting and enhancing entrepreneurial culture.